1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immunology Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Immunology Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monoclonal Antibodies (mAb)
1.4.3 Antibody Drug Conjugates
1.4.4 Interferon and Cytokine therapies
1.4.5 Immunosuppressive medication
1.5 Market by Application
1.5.1 Global Immunology Drug Market Share by Application: 2021-2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cancer Research Centers and Institutes
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Immunology Drug Market
1.8.1 Global Immunology Drug Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Immunology Drug Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Immunology Drug Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Immunology Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Immunology Drug Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Immunology Drug Sales Volume Market Share by Region (2015-2020)
3.2 Global Immunology Drug Sales Revenue Market Share by Region (2015-2020)
3.3 North America Immunology Drug Sales Volume
3.3.1 North America Immunology Drug Sales Volume Growth Rate (2015-2020)
3.3.2 North America Immunology Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Immunology Drug Sales Volume
3.4.1 East Asia Immunology Drug Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Immunology Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Immunology Drug Sales Volume (2015-2020)
3.5.1 Europe Immunology Drug Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Immunology Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Immunology Drug Sales Volume (2015-2020)
3.6.1 South Asia Immunology Drug Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Immunology Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Immunology Drug Sales Volume (2015-2020)
3.7.1 Southeast Asia Immunology Drug Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Immunology Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Immunology Drug Sales Volume (2015-2020)
3.8.1 Middle East Immunology Drug Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Immunology Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Immunology Drug Sales Volume (2015-2020)
3.9.1 Africa Immunology Drug Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Immunology Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Immunology Drug Sales Volume (2015-2020)
3.10.1 Oceania Immunology Drug Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Immunology Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Immunology Drug Sales Volume (2015-2020)
3.11.1 South America Immunology Drug Sales Volume Growth Rate (2015-2020)
3.11.2 South America Immunology Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Immunology Drug Sales Volume (2015-2020)
3.12.1 Rest of the World Immunology Drug Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Immunology Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Immunology Drug Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Immunology Drug Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Immunology Drug Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Immunology Drug Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Immunology Drug Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Immunology Drug Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Immunology Drug Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Immunology Drug Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Immunology Drug Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Immunology Drug Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Immunology Drug Sales Volume Market Share by Type (2015-2020)
14.2 Global Immunology Drug Sales Revenue Market Share by Type (2015-2020)
14.3 Global Immunology Drug Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Immunology Drug Consumption Volume by Application (2015-2020)
15.2 Global Immunology Drug Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Immunology Drug Business
16.1 Abbott Laboratories
16.1.1 Abbott Laboratories Company Profile
16.1.2 Abbott Laboratories Immunology Drug Product Specification
16.1.3 Abbott Laboratories Immunology Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Genentech
16.2.1 Genentech Company Profile
16.2.2 Genentech Immunology Drug Product Specification
16.2.3 Genentech Immunology Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Autoimmune Inc.
16.3.1 Autoimmune Inc. Company Profile
16.3.2 Autoimmune Inc. Immunology Drug Product Specification
16.3.3 Autoimmune Inc. Immunology Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Active Biotech
16.4.1 Active Biotech Company Profile
16.4.2 Active Biotech Immunology Drug Product Specification
16.4.3 Active Biotech Immunology Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Seattle Genetics
16.5.1 Seattle Genetics Company Profile
16.5.2 Seattle Genetics Immunology Drug Product Specification
16.5.3 Seattle Genetics Immunology Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Eli Lilly and Company
16.6.1 Eli Lilly and Company Company Profile
16.6.2 Eli Lilly and Company Immunology Drug Product Specification
16.6.3 Eli Lilly and Company Immunology Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Eisai Co.
16.7.1 Eisai Co. Company Profile
16.7.2 Eisai Co. Immunology Drug Product Specification
16.7.3 Eisai Co. Immunology Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 GlaxoSmithKline plc
16.8.1 GlaxoSmithKline plc Company Profile
16.8.2 GlaxoSmithKline plc Immunology Drug Product Specification
16.8.3 GlaxoSmithKline plc Immunology Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Pfizer
16.9.1 Pfizer Company Profile
16.9.2 Pfizer Immunology Drug Product Specification
16.9.3 Pfizer Immunology Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 F. Hoffmann-La Roche Ltd.
16.10.1 F. Hoffmann-La Roche Ltd. Company Profile
16.10.2 F. Hoffmann-La Roche Ltd. Immunology Drug Product Specification
16.10.3 F. Hoffmann-La Roche Ltd. Immunology Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Bayer AG
16.11.1 Bayer AG Company Profile
16.11.2 Bayer AG Immunology Drug Product Specification
16.11.3 Bayer AG Immunology Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Sanofi Aventis LLC.
16.12.1 Sanofi Aventis LLC. Company Profile
16.12.2 Sanofi Aventis LLC. Immunology Drug Product Specification
16.12.3 Sanofi Aventis LLC. Immunology Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Immunology Drug Manufacturing Cost Analysis
17.1 Immunology Drug Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Immunology Drug
17.4 Immunology Drug Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Immunology Drug Distributors List
18.3 Immunology Drug Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Immunology Drug (2021-2026)
20.2 Global Forecasted Revenue of Immunology Drug (2021-2026)
20.3 Global Forecasted Price of Immunology Drug (2015-2026)
20.4 Global Forecasted Production of Immunology Drug by Region (2021-2026)
20.4.1 North America Immunology Drug Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Immunology Drug Production, Revenue Forecast (2021-2026)
20.4.3 Europe Immunology Drug Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Immunology Drug Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Immunology Drug Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Immunology Drug Production, Revenue Forecast (2021-2026)
20.4.7 Africa Immunology Drug Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Immunology Drug Production, Revenue Forecast (2021-2026)
20.4.9 South America Immunology Drug Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Immunology Drug Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Immunology Drug by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Immunology Drug by Country
21.2 East Asia Market Forecasted Consumption of Immunology Drug by Country
21.3 Europe Market Forecasted Consumption of Immunology Drug by Countriy
21.4 South Asia Forecasted Consumption of Immunology Drug by Country
21.5 Southeast Asia Forecasted Consumption of Immunology Drug by Country
21.6 Middle East Forecasted Consumption of Immunology Drug by Country
21.7 Africa Forecasted Consumption of Immunology Drug by Country
21.8 Oceania Forecasted Consumption of Immunology Drug by Country
21.9 South America Forecasted Consumption of Immunology Drug by Country
21.10 Rest of the world Forecasted Consumption of Immunology Drug by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer